March 01, 2015 3:05 PM ET


Company Overview of Visterra, Inc.

Executive Profile

Steven B. Brugger

Chief Executive Officer, President and Director, Affinivax Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships


Mr. Steven B. Brugger served as the Chief Executive Officer of Visterra, Inc. from November 2010 to July 2013. Mr. Brugger joined Visterra with over 30 years of experience in the biotechnology and pharmaceutical industry. Mr. Brugger served as the Chief Operating Officer at Momenta Pharmaceuticals from September 2007 to November 5, 2010. Mr. Brugger served as Senior Vice President of Strategic Business Operations of Momenta Pharmaceuticals Inc. from April, 2005 to September, ...

Corporate Headquarters

One Kendall Square
Cambridge, Massachusetts 02139

United States

Phone: 617-498-1070
Fax: 617-498-1073

Board Members Memberships

Former Chief Executive Officer and Director
Chief Executive Officer, President and Director


Rutgers, The State University of New Jersey
Susquehanna University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Visterra, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at